Literature DB >> 30783764

Surgical Considerations for Pediatric Snake Bites in Low- and Middle-Income Countries.

Matthew C Hernandez1, Michael Traynor2, John L Bruce3, Wanda Bekker3, Grant L Laing3, Johnathon M Aho2, Victor Y Kong3, Denise B Klinkner4, Martin D Zielinski2, Damian L Clarke3.   

Abstract

BACKGROUND: Snake envenomation is associated with major morbidity especially in low- and middle-income countries and may require fasciotomy. We determined patient factors associated with the need for fasciotomy after venomous snake bites in children located in KwaZulu-Natal, South Africa.
METHODS: Single institutional review of historical data (2012-2017) for children (<18 years) sustaining snake envenomation was performed. Clinical data, management, and outcomes were abstracted. Syndromes after snake bite were classified according to Blaylock nomenclature: progressive painful swelling (PPS), progressive weakness (PW), or bleeding (B), as it is difficult to reliably identify the species of snake after a bite. Comparative and multivariable analyses to determine factors associated with fasciotomy were performed.
RESULTS: There were 72 children; mean age was 7 (±3) years, 59% male. Feet were most commonly affected (n = 27, 38%) followed by legs (n = 18, 25%). Syndromes (according to Blaylock) included PPS (n = 63, 88%), PW (n = 5, 7%), and B (n = 4, 5%). Eighteen patients underwent fasciotomy, and one required above knee amputation. Nine patients received anti-venom. Few patients (15%) received prophylactic beta-lactam antibiotics. Hemoglobin < 11 mg/dL, leukocytosis, INR >1.2, and age-adjusted shock index were associated with fasciotomy. On regression, age-adjusted shock index and hemoglobin concentration < 11 mg/dL, presentation >24 h after snake bite, and INR >1.2 were independently associated with fasciotomy. Model sensitivity was 0.89 and demonstrated good fit.
CONCLUSIONS: Patient factors were associated with the fasciotomy. These factors, coupled with clinical examination, may identify those who need early operative intervention. Improving time to treatment and the appropriate administration of anti-venom will minimize the need for surgery. LEVEL OF EVIDENCE: III.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30783764     DOI: 10.1007/s00268-019-04953-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  26 in total

1.  Amputation and disability following snakebite in Nigeria.

Authors:  S B Abubakar; A G Habib; J Mathew
Journal:  Trop Doct       Date:  2010-04       Impact factor: 0.731

2.  Algorithmic approach to the prevention of unnecessary fasciotomy in extremity snake bite.

Authors:  Arif Türkmen; Metin Temel
Journal:  Injury       Date:  2016-10-21       Impact factor: 2.586

3.  Shock index, pediatric age-adjusted (SIPA) is more accurate than age-adjusted hypotension for trauma team activation.

Authors:  Shannon N Acker; Brooke Bredbeck; David A Partrick; Ann M Kulungowski; Carlton C Barnett; Denis D Bensard
Journal:  Surgery       Date:  2016-11-01       Impact factor: 3.982

4.  Prospective, consecutive case series of 158 snakebite patients treated at Savannakhet provincial hospital, Lao People's Democratic Republic with high incidence of anaphylactic shock to horse derived F(ab')2 antivenom.

Authors:  Inthanomchanh Vongphoumy; Phankham Chanthilat; Phongmany Vilayvong; Joerg Blessmann
Journal:  Toxicon       Date:  2016-03-16       Impact factor: 3.033

5.  Using a hybrid electronic medical record system for the surveillance of adverse surgical events and human error in a developing world surgical service.

Authors:  Grant Laing; John Bruce; David Skinner; Nikki Allorto; Colleen Aldous; Sandie Thomson; Damian Clarke
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

6.  Defining the need for surgical intervention following a snakebite still relies heavily on clinical assessment: The experience in Pietermaritzburg, South Africa.

Authors:  J P Pattinson; V Y Kong; J L Bruce; G V Oosthuizen; W Bekker; G L Laing; D Wood; P Brysiewicz; D L Clarke
Journal:  S Afr Med J       Date:  2017-11-27

7.  The incidence, spectrum and outcome of paediatric trauma managed by the Pietermaritzburg Metropolitan Trauma Service.

Authors:  V Manchev; J L Bruce; G V Oosthuizen; G L Laing; D L Clarke
Journal:  Ann R Coll Surg Engl       Date:  2015-05       Impact factor: 1.891

8.  Mortality and Disability-Adjusted Life-Years (Dalys) for Common Neglected Tropical Diseases in Ethiopia, 1990-2015: Evidence from the Global Burden of Disease Study 2015.

Authors:  A Deribew; B Kebede; G A Tessema; Y A Adama; A Misganaw; T Gebre; A Hailu; S Biadgilign; A Amberbir; B Desalegn; A A Abajobir; O Shafi; S F Abera; N Negussu; B Mengistu; A T Amare; A Mulugeta; Z Kebede; B Mengistu; Z Tadesse; M Sileshi; M Tamiru; E A Chromwel; S D Glenn; J D Stanaway; K Deribe
Journal:  Ethiop Med J       Date:  2017

9.  Snakebite is Under Appreciated: Appraisal of Burden from West Africa.

Authors:  Abdulrazaq G Habib; Andreas Kuznik; Muhammad Hamza; Maryam I Abdullahi; Basheer A Chedi; Jean-Philippe Chippaux; David A Warrell
Journal:  PLoS Negl Trop Dis       Date:  2015-09-23

10.  Ocular Manifestations of Venomous Snake Bite over a One-year Period in a Tertiary Care Hospital.

Authors:  K V Praveen Kumar; S Praveen Kumar; Nirupama Kasturi; Shashi Ahuja
Journal:  Korean J Ophthalmol       Date:  2015-07-21
View more
  3 in total

1.  Management and Prognosis of Snake Envenomation Among Pediatric Patients: A National Database Study.

Authors:  Lin-Chi Chiang; Chung-Hsien Chaou; Yi-Yun Li; Chen-June Seak; Shiuan-Ruey Yu; Chih-Chuan Lin
Journal:  J Acute Med       Date:  2022-03-01

Review 2.  Snake Bite Management: A Scoping Review of the Literature.

Authors:  Jeffrey J Russell; Anna Schoenbrunner; Jeffrey E Janis
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-04-29

3.  Snakebite envenoming in humanitarian crises and migration: A scoping review and the Médecins Sans Frontières experience.

Authors:  Gabriel Alcoba; Julien Potet; Renaud Vatrinet; Saschveen Singh; Carolina Nanclares; Alexandra Kruse; Margriet Den Boer; Lucas Molfino; Koert Ritmeijer
Journal:  Toxicon X       Date:  2021-12-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.